Literature DB >> 19610151

Fulminant amoebic colitis during chemotherapy for advanced gastric cancer.

Noboru Hanaoka1, Katsuhiko Higuchi, Satoshi Tanabe, Tohru Sasaki, Kenji Ishido, Takako Ae, Wasaburo Koizumi, Katsunori Saigenji.   

Abstract

A 52-year-old man had bloody stools during chemotherapy for gastric cancer. A colonoscopy revealed necrotizing ulcer-like changes. A biopsy confirmed the presence of amoebic trophozoites. Subsequently, peritonitis with intestinal perforation developed, and emergency peritoneal lavage and colostomy were performed. After surgery, endotoxin adsorption therapy was performed and metronidazole was given. Symptoms of peritonitis and colonitis resolved. However, the patient's general condition worsened with the progression of gastric cancer. The patient died 50 d after surgery. Fulminant amoebic colitis is very rarely associated with chemotherapy. Amoebic colitis should be considered in the differential diagnosis of patients who have bloody stools during chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19610151      PMCID: PMC2712911          DOI: 10.3748/wjg.15.3445

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  10 in total

1.  Colonic perforations in amoebiasis.

Authors:  E M BARKER
Journal:  S Afr Med J       Date:  1958-06-21

2.  Fulminant amebic colitis.

Authors:  H Aristizábal; J Acevedo; M Botero
Journal:  World J Surg       Date:  1991 Mar-Apr       Impact factor: 3.352

3.  Amoebiasis.

Authors:  K Juniper
Journal:  Clin Gastroenterol       Date:  1978-01

4.  Acanthamoebiasis and immunosuppression. Case report.

Authors:  A J Martinez
Journal:  J Neuropathol Exp Neurol       Date:  1982-09       Impact factor: 3.685

Review 5.  Amoebiasis.

Authors:  Samuel L Stanley
Journal:  Lancet       Date:  2003-03-22       Impact factor: 79.321

6.  Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group.

Authors:  W Koizumi; M Kurihara; S Nakano; K Hasegawa
Journal:  Oncology       Date:  2000-04       Impact factor: 2.935

7.  Optimal dose-finding study of bi-weekly paclitaxel in unresectable advanced or recurrent gastric cancer.

Authors:  Wasaburo Koizumi; Satoshi Tanabe; Katsuhiko Higuchi; Toru Sasaki; Shosuke Nakayama; Kento Nakatani; Ken Nishimura; Takuya Shimoda; Mizutomo Azuma; Kenji Ishido; Katsunori Saigenji
Journal:  Anticancer Res       Date:  2006 Sep-Oct       Impact factor: 2.480

8.  Present characteristics of symptomatic Entamoeba histolytica infection in the big cities of Japan.

Authors:  K Ohnishi; Y Kato; A Imamura; M Fukayama; T Tsunoda; Y Sakaue; M Sakamoto; H Sagara
Journal:  Epidemiol Infect       Date:  2004-01       Impact factor: 2.451

9.  Fulminant amebic colitis: analysis of 55 cases.

Authors:  T Takahashi; A Gamboa-Dominguez; T J Gomez-Mendez; J M Remes; V Rembis; D Martinez-Gonzalez; J Gutierrez-Saldivar; J C Morales; J Granados; J Sierra-Madero
Journal:  Dis Colon Rectum       Date:  1997-11       Impact factor: 4.585

10.  Corticosteroids and liver amoebiasis.

Authors:  P C Stuiver; T J Goud
Journal:  Br Med J       Date:  1978-08-05
  10 in total
  1 in total

1.  Development of perianal ulcer as a result of acute fulminant amoebic colitis.

Authors:  Takayuki Torigoe; Yoshifumi Nakayama; Koji Yamaguchi
Journal:  World J Gastroenterol       Date:  2012-09-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.